Impax Labs Acquires Two Generic Products From Actavis - Quick Facts

By RTT News, 
A A A


(RTTNews.com) - Impax Laboratories, Inc. ( IPXL ) announced that it has acquired two generic products from Actavis plc ( ACT ) for cash consideration pursuant to a Purchase Agreement and a Supply Agreement. Financial terms of the agreement were not disclosed.

The company said the acquisition includes one product marketed under an Abbreviated New Drug Application or ANDA - Ursodiol tablet - and one approved ANDA that is not yet marketed - Lamotrigine orally disintegrating tablet or ODT.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com



This article appears in: News Headlines

Referenced Stocks: ACT , IPXL

RTT News


More from RTT News:

Related Videos

Stocks

Referenced

Most Active by Volume

25,464,180
  • $16.085 ▲ 0.47%
22,987,076
  • $102.40 ▲ 0.15%
22,561,672
  • $19.4228 ▲ 1.58%
19,305,074
  • $49.49 ▲ 0.12%
16,084,523
  • $34.8049 ▲ 0.45%
15,529,027
  • $13.055 ▼ 0.42%
15,351,059
  • $53.745 ▲ 18.67%
13,433,099
  • $74.72 ▲ 1.17%
As of 8/29/2014, 01:26 PM